0.0502
price down icon49.80%   -0.0498
 
loading
Vincerx Pharma Inc stock is traded at $0.0502, with a volume of 118.41K. It is down -49.80% in the last 24 hours and down -90.69% over the past month.
See More
Previous Close:
$0.10
Open:
$0.0555
24h Volume:
118.41K
Relative Volume:
0.10
Market Cap:
$697.73K
Revenue:
-
Net Income/Loss:
$-48.85M
P/E Ratio:
-0.0217
EPS:
-2.31
Net Cash Flow:
$-46.25M
1W Performance:
-62.34%
1M Performance:
-90.69%
6M Performance:
-99.33%
1Y Performance:
-99.66%
1-Day Range:
Value
$0.05
$0.06
1-Week Range:
Value
$0.05
$0.131
52-Week Range:
Value
$0.05
$18.70

Vincerx Pharma Inc Stock (VINC) Company Profile

Name
Name
Vincerx Pharma Inc
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2025-04-01
Name
Latest SEC Filings
Name
VINC's Discussions on Twitter

Compare VINC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
VINC
Vincerx Pharma Inc
0.0502 697.73K 0 -48.85M -46.25M -2.31
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.49 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.86 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
620.97 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
254.85 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.46 24.70B 3.81B -644.79M -669.77M -6.24

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-14-22 Initiated H.C. Wainwright Buy
Dec-23-21 Initiated Cantor Fitzgerald Overweight
Nov-01-21 Initiated SVB Leerink Outperform
Sep-13-21 Initiated Laidlaw Buy
Aug-25-21 Initiated B. Riley Securities Buy

Vincerx Pharma Inc Stock (VINC) Latest News

pulisher
Apr 28, 2025

Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace

Apr 28, 2025
pulisher
Apr 26, 2025

Stock Market Recap: Vincerx Pharma Inc (VINC) Concludes at 0.26, a 1.11 Surge/Decline - DWinneX

Apr 26, 2025
pulisher
Apr 23, 2025

Investing in Vincerx Pharma Inc [VINC]: What You Must Know - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Post-Trade Analysis: Vincerx Pharma Inc (VINC) Slides -24.98, Closing at 0.10 - DWinneX

Apr 23, 2025
pulisher
Apr 22, 2025

Vincerx Pharma Inc (VINC) Stock: From Low to High in 52 Weeks - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Why Vincerx Pharma Inc Stock Might Make Sense If Bought Today - Stocksregister

Apr 22, 2025
pulisher
Apr 21, 2025

Vincerx Pharma Stock Price, Quotes and Forecasts | NASDAQ:VINC - Benzinga

Apr 21, 2025
pulisher
Apr 21, 2025

The Vincerx Pharma Inc (VINC) Stock Is Headed for a Correction - uspostnews.com

Apr 21, 2025
pulisher
Apr 21, 2025

VINC stock touches 52-week low at $0.17 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 21, 2025
pulisher
Apr 21, 2025

VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com India

Apr 21, 2025
pulisher
Apr 17, 2025

Nasdaq to delist Vincerx Pharma by April 23 By Investing.com - Investing.com South Africa

Apr 17, 2025
pulisher
Apr 17, 2025

Nasdaq to delist Vincerx Pharma by April 23 - Investing.com India

Apr 17, 2025
pulisher
Apr 17, 2025

Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC - TradingView

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma announces plan to delist from Nasdaq - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma Announces Suspension and Intent to Delist Common Stock from Nasdaq - Nasdaq

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - GlobeNewswire

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma Announces Complete Liquidation and Nasdaq Exit: What Happens to Your Shares? - Stock Titan

Apr 17, 2025
pulisher
Apr 17, 2025

Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer - GlobeNewswire

Apr 17, 2025
pulisher
Apr 16, 2025

Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Expands By 99.4% - Defense World

Apr 16, 2025
pulisher
Apr 12, 2025

vincerx pharma cancels merger, initiates wind-down activities - Investing.com Australia

Apr 12, 2025
pulisher
Apr 12, 2025

vincerx pharma cancels merger, initiates wind-down activities By Investing.com - Investing.com India

Apr 12, 2025
pulisher
Apr 11, 2025

Vincerx Pharma Inc Initiates Wind Down and Asset Monetization - TipRanks

Apr 11, 2025
pulisher
Apr 09, 2025

VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles - Investing.com

Apr 09, 2025
pulisher
Apr 09, 2025

Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews

Apr 09, 2025
pulisher
Apr 09, 2025

US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert - Benzinga

Apr 09, 2025
pulisher
Apr 09, 2025

Vincerx Pharma ends merger talks, begins asset wind-down By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 08, 2025

Financially struggling drugmaker's potential rescue falls apart. It now will wind downSan Francisco Business Times - The Business Journals

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx terminates letter of intent with Global Digital, initiates wind down - TipRanks

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx Pharma ends merger talks, begins asset wind-down - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - The Manila Times

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx Pharma Begins Wind-Down After Terminating Merger Plan With QumulusAI - marketscreener.com

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

Failed Merger Forces Vincerx Pharma to Begin Company Wind-Down: What's Next for Investors? - Stock Titan

Apr 08, 2025
pulisher
Mar 31, 2025

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 28, 2025

Vincerx Pharma (VINC) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Vincerx Pharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 25, 2025

Vincerx Pharma Inc expected to post a loss of $3.40 a shareEarnings Preview - TradingView

Mar 25, 2025
pulisher
Mar 19, 2025

Such Is The Power Of Vincerx Pharma Inc (NASDAQ: VINC) - Stocks Register

Mar 19, 2025
pulisher
Mar 19, 2025

Vincerx Pharma plans reverse merger with QumulusAI By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

VINC stock touches 52-week low at $0.73 amid sharp annual decline - Investing.com UK

Mar 18, 2025

Vincerx Pharma Inc Stock (VINC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.63
price up icon 0.19%
$69.86
price up icon 0.24%
$32.54
price up icon 1.06%
$24.11
price up icon 2.75%
$104.00
price up icon 1.94%
biotechnology ONC
$249.46
price up icon 1.86%
Cap:     |  Volume (24h):